EosGene Tx
EosGene Therapeutics
Providing patients
with life-changing cures
What We Do
Our approach employs the revolutionary CRISPR editing tool to precisely target the disease-associated gene, paving the way for therapeutic breakthroughs.
To ensure both effectiveness and safety of the therapy, we have developed an innovative liposome delivery technology that achieves the spatial-temporal release of CRISPR agents to the affected cells.​
​
Our objective is to halt or reverse the progression of diabetic retinopathy by correcting underpinning genetic dysfunctions at their source.
​​
Who We Are
EosGene brings together world-class scientists with expertise in bio- and chemical technologies and highly experienced business leaders,
​
Our team of medical advisors guides our preclinical and clinical studies.
​
With our ground-breaking liposome delivery technology, we are at the forefront of the emerging wave of genetic cures.
These will transform the available treatment options for currently untreatable genetic conditions.
​
​
​
